Hypersecretory Disorders and Botulinum Toxin

被引：1
作者：
Hanagasi, Hasmet A. [1 ]
机构：
[1] Istanbul Univ, Istanbul Tip Fak, Norol Anabilim Dali, Davranis Norol & Hareket Bozukluklari Birimi, TR-34094 Istanbul, Turkey
来源：
NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY | 2010年 / 47卷
关键词：
Botulinum toxin; hyperhidrosis; sialorrhoea; Frey's syndrome; excessive lacrimation; chronic rhinitis; QUALITY-OF-LIFE; PRIMARY AXILLARY HYPERHIDROSIS; DOUBLE-BLIND; PALMAR HYPERHIDROSIS; FOCAL HYPERHIDROSIS; PARKINSONS-DISEASE; FREYS-SYNDROME; SWEAT GLANDS; A TOXIN; AMERICAN-ACADEMY;
D O I：
10.4274/npa.y5920
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
An increase in the popularity of botulinum toxin for treatment of salivary gland disorders has been observed in recent years. Hyperhidrosis is characterized by excessive sweat production, beyond the required quantity to return increased body temperature to normal. Sialorrhoea is a common symptom in many neurodegenerative disorders. Hyperhidrosis and sialorrhea can cause both physical and psychosocial disability. Many reports on the use of botulinum toxin in hypersecretory disorders have shown favourable results with minimal side effects. (Archives of Neuropsychiatry 2010; 47 Supplement: 48-51)
引用
收藏
页码：48 / 51
页数：4
相关论文
共 53 条
  • [1] Pilot study of the safety and efficacy of MyoblocTM (botulinum toxin type B) for treatment of axillary hyperhidrosis
    Baumann, L
    Slezinger, A
    Halem, M
    Vujevich, J
    Martin, LK
    Black, L
    Bryde, J
    [J]. INTERNATIONAL JOURNAL OF DERMATOLOGY, 2005, 44 (05) : 418 - 424
  • [2] Bell G., 1980, TXB PHYSL, P36
  • [3] Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: Results of an open-label study
    Campanati, A
    Penna, L
    Guzzo, T
    Menotta, L
    Silvestri, B
    Lagalla, G
    Gesuita, R
    Offidani, A
    [J]. CLINICAL THERAPEUTICS, 2003, 25 (01) : 298 - 308
  • [4] Treatment of Frey's syndrome with botulinum toxin type B
    Cantarella, Giovanna
    Berlusconi, Alessandra
    Mele, Vincenzo
    Cogiamanian, Filippo
    Barbieri, Sergio
    [J]. OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2010, 143 (02) : 214 - 218
  • [5] Histopathological and radiological investigations of the influence of botulinum toxin on the submandibular gland of the rat
    Coskun, Berna Uslu
    Savk, Hayati
    Cicek, Esin Derin
    Basak, Tulay
    Basak, Muzaffer
    Dadas, Burhan
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2007, 264 (07) : 783 - 787
  • [6] Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis
    Costa, Joao
    Rocha, Maria Luz
    Ferreira, Joaquim
    Evangelista, Teresinha
    Coelho, Miguel
    de Carvalho, Mamede
    [J]. JOURNAL OF NEUROLOGY, 2008, 255 (04) : 545 - 550
  • [7] Repeated Botulinum Toxin Type A Injections to Treat Patients With Frey Syndrome
    de Bree, Remco
    Duyndam, Jeff E.
    Kuik, Dirk J.
    Leemans, C. Rene
    [J]. ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2009, 135 (03) : 287 - 290
  • [8] Ultrasound-guided versus 'blind' intraparotid injections of botulinum toxin-A for the treatment of sialorrhoea in patients with Parkinson's disease
    Dogu, O
    Apaydin, D
    Sevim, S
    Talas, DU
    Aral, M
    [J]. CLINICAL NEUROLOGY AND NEUROSURGERY, 2004, 106 (02) : 93 - 96
  • [9] Comparing BotoxA® and XeominA® for axillar hyperhidrosis
    Dressler, Dirk
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (03) : 317 - 319
  • [10] Treatment of gustatory sweating (Frey's syndrome) with botulinum toxin A
    Eckardt, A
    Kuettner, C
    [J]. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2003, 25 (08): : 624 - 628
123456